Alterola Biotech Company Top Insiders
ABTI Stock | USD 0.01 0 32.76% |
Alterola Biotech employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Assessment of Alterola Biotech's management performance can provide insight into the firm performance.
Colin BSc Insider COO Director |
Timothy Rogers Insider Ex CFO |
Alterola |
Alterola Biotech Management Team Effectiveness
The company has return on total asset (ROA) of (0.6669) % which means that it has lost $0.6669 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2729) %, meaning that it created substantial loss on money invested by shareholders. Alterola Biotech's management efficiency ratios could be used to measure how well Alterola Biotech manages its routine affairs as well as how well it operates its assets and liabilities.Alterola Biotech Workforce Comparison
Alterola Biotech is rated fourth in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 8,617. Alterola Biotech adds roughly 6.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Alterola Biotech Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Alterola Biotech Price Series Summation is a cross summation of Alterola Biotech price series and its benchmark/peer.
Alterola Biotech Notable Stakeholders
An Alterola Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Alterola Biotech often face trade-offs trying to please all of them. Alterola Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Alterola Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Colin BSc | COO Director | Profile | |
Timothy Rogers | Ex CFO | Profile | |
Seamus McAuley | S Director | Profile | |
David OBE | CEO Director | Profile | |
Hunter Land | VP Director | Profile | |
Dominic Schiller | Chief Counsel | Profile |
About Alterola Biotech Management Performance
The success or failure of an entity such as Alterola Biotech often depends on how effective the management is. Alterola Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Alterola management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Alterola management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products production of active pharmaceutical ingredients and food-grade ingredients and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech is traded on OTC Exchange in the United States.
Alterola Biotech Workforce Analysis
Traditionally, organizations such as Alterola Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Alterola Biotech within its industry.Alterola Biotech Manpower Efficiency
Return on Alterola Biotech Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.1M | |
Net Loss Per Executive | 1.1M |
Complementary Tools for Alterola Pink Sheet analysis
When running Alterola Biotech's price analysis, check to measure Alterola Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterola Biotech is operating at the current time. Most of Alterola Biotech's value examination focuses on studying past and present price action to predict the probability of Alterola Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterola Biotech's price. Additionally, you may evaluate how the addition of Alterola Biotech to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |